Matteo Ponzo

Equipe De Recherche Labellisée ERL CNRS 9215, University Of Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.

TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.

Journal: Journal for immunotherapy of cancer

Published: October 04, 2024

PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination.

PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination.

Journal: Cancer immunology research

Published: April 04, 2023

Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.

Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.

Journal: Cancers

Published: October 21, 2022

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

Journal: Cancers

Published: July 01, 2022

Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.

Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: March 30, 2021

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.

Journal: Cellular and molecular gastroenterology and hepatology

Published: June 30, 2020

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

Journal: eLife

Published: May 07, 2020

Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 19, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026